{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:43:12Z","timestamp":1772772192361,"version":"3.50.1"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2012,7,25]],"date-time":"2012-07-25T00:00:00Z","timestamp":1343174400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0041858","type":"journal-article","created":{"date-parts":[[2012,7,25]],"date-time":"2012-07-25T21:36:21Z","timestamp":1343252181000},"page":"e41858","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":35,"title":["Minocycline Inhibits Alkali Burn-Induced Corneal Neovascularization in Mice"],"prefix":"10.1371","volume":"7","author":[{"given":"Ou","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao-lian","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin-wu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-fang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong-biao","family":"Pi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-you","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,7,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0039-6257(96)00007-0","article-title":"Chemical injuries of the eye: current concepts in pathophysiology and therapy.","volume":"41","author":"MD Wagoner","year":"1997","journal-title":"Surv Ophthalmol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2006.02.037","article-title":"Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration.","volume":"142","author":"ZF Bashshur","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"ref3","first-page":"797","article-title":"KH906, a recombinant human VEGF receptor fusion protein, is a new effective topical treatment for corneal neovascularization.","volume":"17","author":"T Li","year":"2011","journal-title":"Mol Vis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00003226-199807000-00011","article-title":"Topical modulation of interleukin-1 activity in corneal neovascularization.","volume":"17","author":"MR Dana","year":"1998","journal-title":"Cornea"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.preteyeres.2010.01.002","article-title":"Novel aspects of corneal angiogenic and lymphangiogenic privilege.","volume":"29","author":"D Ellenberg","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.phrs.2011.06.013","article-title":"The non-antibiotic properties of tetracyclines: Clinical potential in ophthalmic disease.","volume":"64","author":"TJ Federici","year":"2011","journal-title":"Pharmacol Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1080\/02713680802245772","article-title":"Inhibitory effect of oral doxycycline on neovascularization in a rat corneal alkali burn model of angiogenesis.","volume":"33","author":"D Liang","year":"2008","journal-title":"Curr Eye Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.exer.2006.02.004","article-title":"Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye.","volume":"83","author":"CS De Paiva","year":"2006","journal-title":"Exp Eye Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00417-010-1539-y","article-title":"The effect of doxycycline temperature-sensitive hydrogel on inhibiting the corneal neovascularization induced by BFGF in rats.","volume":"249","author":"WR Su","year":"2011","journal-title":"Graef Arch Clin Exp"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/417074a","article-title":"Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice.","volume":"417","author":"S Zhu","year":"2002","journal-title":"Nature"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/brain\/awf133","article-title":"Targeting leukocyte MMPs and transmigration - Minocycline as a potential therapy for multiple sclerosis.","volume":"125","author":"V Brundula","year":"2002","journal-title":"Brain"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.ico.0000220767.73660.3a","article-title":"The effect of combinations of flurbiprofen, low molecular weight heparin, and doxycycline on the inhibition of corneal neovascularization.","volume":"25","author":"GA Peyman","year":"2006","journal-title":"Cornea"},{"key":"ref13","first-page":"672","article-title":"Angiogenesis inhibition by minocycline.","volume":"51","author":"RJ Tamargo","year":"1991","journal-title":"Cancer Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.neuint.2006.10.008","article-title":"Comparison of doxycycline and minocycline in the inhibition of VEGF-induced smooth muscle cell migration.","volume":"50","author":"JS Yao","year":"2007","journal-title":"Neurochem Int"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S1570-0232(03)00247-2","article-title":"Liquid chromatographic determination of minocycline in brain-to-plasma distribution studies in the rat.","volume":"791","author":"M Colovic","year":"2003","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/1352458506070319","article-title":"The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study.","volume":"13","author":"RK Zabad","year":"2007","journal-title":"Mult Scler"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.3171\/FOC.2008.25.11.E14","article-title":"Protection and repair of the injured spinal cord: a review of completed, ongoing, and planned clinical trials for acute spinal cord injury.","volume":"25","author":"GWJ Hawryluk","year":"2008","journal-title":"Neurosurgical Focus"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(07)70270-3","article-title":"Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.","volume":"6","author":"PH Gordon","year":"2007","journal-title":"Lancet Neurol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00002826-200309000-00001","article-title":"Neuroprotection in Hungtington's disease.","volume":"26","author":"T Lahousen","year":"2003","journal-title":"Clin Neuropharmacol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/WNF.0b013e3181342f32","article-title":"A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results.","volume":"31","author":"K Kieburtz","year":"2008","journal-title":"Clin Neuropharmacol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bbr.2008.09.040","article-title":"Minocycline and neurodegenerative diseases.","volume":"196","author":"HS Kim","year":"2009","journal-title":"Behav Brain Res"},{"key":"ref22","first-page":"1389","article-title":"Inhibition of mouse alkali burn induced-corneal neovascularization by recombinant adenovirus encoding human vasohibin-1.","volume":"16","author":"SY Zhou","year":"2010","journal-title":"Mol Vis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.nbd.2004.07.012","article-title":"Clinical potential of minocycline for neurodegenerative disorders.","volume":"17","author":"D Blum","year":"2004","journal-title":"Neurobiol Dis"},{"key":"ref24","first-page":"473","article-title":"Quantitation of corneal neovascularization using computerized image analysis.","volume":"58","author":"AD Proia","year":"1988","journal-title":"Lab Invest"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/ICO.0b013e31814b8a28","article-title":"Expression of matrix metalloproteinase 2 and 9 in experimentally wounded canine corneas and spontaneous chronic corneal epithelial defects.","volume":"26","author":"RT Carter","year":"2007","journal-title":"Cornea"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00007691-198206000-00002","article-title":"Minocycline.","volume":"4","author":"M Jonas","year":"1982","journal-title":"Ther Drug Monit"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bbrc.2008.07.121","article-title":"VEGF receptor protein-tyrosine kinases: structure and regulation.","volume":"375","author":"R Roskoski Jr","year":"2008","journal-title":"BiochemBiophys Res Commun"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/01.RES.0000118600.91698.BB","article-title":"Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability.","volume":"94","author":"R Cao","year":"2004","journal-title":"Circ Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1350-9462(99)00007-5","article-title":"Growth factors: importance in wound healing and maintenance of transparency of the cornea.","volume":"19","author":"J Imanishi","year":"2000","journal-title":"Prog Retin Eye Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.exer.2008.02.001","article-title":"Topical interleukin-1 receptor antagonist inhibits inflammatory cell infiltration into the cornea.","volume":"86","author":"WM Stapleton","year":"2008","journal-title":"Exp Eye Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0014-4835(02)00293-2","article-title":"Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury.","volume":"76","author":"J Yamada","year":"2003","journal-title":"Exp Eye Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejphar.2011.04.014","article-title":"Minocycline attenuates the development of diabetic neuropathic pain: Possible anti-inflammatory and anti-oxidant mechanisms.","volume":"661","author":"K Pabreja","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/80538","article-title":"Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease.","volume":"6","author":"M Chen","year":"2000","journal-title":"Nat Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.4049\/jimmunol.161.7.3340","article-title":"Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing.","volume":"161","author":"U Schonbeck","year":"1998","journal-title":"J Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/S0161-6420(86)33570-X","article-title":"Systemic tetracycline hydrochloride as adjunctive therapy in the treatment of persistent epithelial defects.","volume":"93","author":"HD Perry","year":"1986","journal-title":"Ophthalmology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"9108","DOI":"10.1167\/iovs.11-7255","article-title":"Doxycycline Enhances the Inhibitory Effects of Bevacizumab on Corneal Neovascularization and Prevents Its Side Effects.","volume":"52","author":"WR Su","year":"2011","journal-title":"Invest Ophth Vis Sci"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000055693","article-title":"Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in inflammation-induced corneal neovascularization.","volume":"33","author":"DH Ma","year":"2001","journal-title":"Ophthalmic Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00003226-200005000-00003","article-title":"Tetracyclines and the treatment of corneal stromal ulceration: a review.","volume":"19","author":"RA Ralph","year":"2000","journal-title":"Cornea"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000468621","article-title":"Plasminogen activators and matrix metalloproteinases in angiogenesis.","volume":"49","author":"P Mignatti","year":"1996","journal-title":"Enzyme Protein"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0014-5793(01)02897-6","article-title":"Diminished corneal angiogenesis in gelatinase A-deficient mice.","volume":"508","author":"T Kato","year":"2001","journal-title":"Febs Letters"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1006\/exer.1999.0790","article-title":"Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization.","volume":"70","author":"A Kvanta","year":"2000","journal-title":"Exp Eye Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-2202-7-56","article-title":"Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke.","volume":"7","author":"LS Machado","year":"2006","journal-title":"Bmc Neurosci"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1128\/AAC.50.5.1798-1804.2006","article-title":"Minocycline impedes African trypanosome invasion of the brain in a murine model.","volume":"50","author":"W Masocha","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/jor.21006","article-title":"Synoviocytes are more sensitive than cartilage to the effects of minocycline and doxycycline on IL-1alpha and MMP-13-induced catabolic gene responses.","volume":"28","author":"LA Fortier","year":"2010","journal-title":"J Orthop Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1600-0765.1991.tb01626.x","article-title":"Suppression of human neutrophil functions by tetracyclines.","volume":"26","author":"WL Gabler","year":"1991","journal-title":"J Periodontal Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/jac\/49.2.411","article-title":"Modulation of oxidative burst of neutrophils by doxycycline in patients with acute myocardial infarction.","volume":"49","author":"S Takeshita","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"ref47","first-page":"508","article-title":"Antibiotics: origin, nature, and properties.","year":"1978","journal-title":"American Society for Microbiology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1089\/neu.2010.1738","article-title":"Minocycline restores sAPP alpha levels and reduces the late histopathological consequences of traumatic brain injury in mice.","volume":"28","author":"E Siopi","year":"2011","journal-title":"J Neurotrauma"},{"key":"ref49","article-title":"Nanoliposomal minocycline for ocular drug delivery. Nanomedicine.","author":"JM Kaiser","year":"2012"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0041858","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T17:31:53Z","timestamp":1687627913000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0041858"}},"subtitle":[],"editor":[{"given":"Fu-Shin","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,7,25]]},"references-count":49,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2012,7,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0041858","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,25]]}}}